Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression.
Journal of psychopharmacology (Oxford, England) 2025 Sarah Pereira Gomes, Sofia Rodrigues Lima, Fabio Gomes de Matos Souza et al. 1 citation
The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.